Abdala, the first Latin American anti-SARS-CoV-2 vaccine. Photo: Ismael Francisco / Cubadebate.
–
One of the Cuban Covid-19 vaccines (Abdala) is now available at vaccination sites in Saint Vincent and the Grenadines. The Health Ministry made the announcement through its Facebook page.
Abdala is produced at the Center for Genetic Engineering and Biotechnology (CIGB) in Havana. The center reported in July that Abdala, a three-dose vaccine, was more than 92% effective in phase III trials that included more than 48,000 participants.
The COVID-19 vaccines available in Saint Vincent and the Grenadines are:
Abdala – 3 doses – 2 week intervals (best given in groups of 10) Sputnik V (component 1 and 2) – 21 day interval Sputnik Light (component 1) – One dose AstraZeneca – 4 to 12 week range Pfizer – 21 day interval
As of December 16, according to the St. Vincent and the Grenadines coronavirus report, the total number of vaccines administered was 59,702 – First dose 33,192 and Second dose – 25,261.